Futura Medical PLC (AIM:FUM, OTC:FAMDF)’s MED3000 erectile dysfunction gel is in a "strong position" to be approved by the US Food and Drug Administration.
That’s according to the company’s broker Liberum, which reckons the shares are worth 121p each – a 210% premium to the current share price.
i3 Energy PLC (AIM:I3E, TSX:ITE, OTC:ITEEF) confirmed its monthly dividend, 0.1425p per share, totalling £1.69mln – with an ex-dividend date of 13 October, a record date of 14 October, and payment on 4 November.
CentralNic Group PLC (AIM:CNIC) noted that Kestrel Partners LLP, part owned by non-executive director Max Royde, bought 12,000 shares in the company at an average price of 112.833p. It increases Kestral’s interest in CentralNic to 63,17mln shares, including 17.92mln shares in which Royde is deemed to have a beneficial interest.